BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«KIR2DL3

Below is an extended KIR2DL3 research listing. Click here to return to the KIR2DL3 main in depth entry.

Recent Publications on KIR2DL3:

Cutting edge: selective expression of inhibitory or activating killer cell Ig-like receptors in circulating CD4+ T lymphocytes. 14th August, 2008
Institut National de la Sante et de la Recherche Medicale Unite 841,
Extracellular domain alterations impact surface expression of stimulatory natural killer cell receptor KIR2DS5.
In the human killer cell immunoglobulin-like receptors, KIR2DL2, and...
Direct Link
7th August, 2008
Department of Oncology, Lombardi Cancer Center, Georgetown University,
[Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation] 12th July, 2008
Department of Hematology, General Hospital of Chinese People's Liberation
Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3. 11th June, 2008
Department of Structural Biology, School of Medicine, Stanford University,
Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack.
Hair follicles (HFs) enjoy a relative immune privilege (IP) that is...
Direct Link
20th May, 2008
Department of Dermatology, Hamamatsu University School of Medicine,
Expression of complement regulatory proteins on human natural killer cell subsets.
The cell surface complement regulatory (CReg) proteins CD46, CD55 and CD59...
Direct Link
28th February, 2008
Division of Immunology, School of Infection and Host Defence, University
Associations of killer cell immunoglobulin-like receptor genes with complications of rheumatoid arthritis.
We investigated whether killer cell immunoglobulin-like receptor (KIR)...
Direct Link
9th February, 2008
Department of Clinical Immunology, Ludwik Hirszfeld Institute of
KIR/HLA ligand incompatibility in kidney transplantation.
BACKGROUND: The polymorphic family of killer-cell immunoglobulin-like...
Direct Link
30th January, 2008
Institute of Medical Immunology, Charite Universitatsmedizin Berlin,
[Analysis of natural killer cell immunoglobulin-like receptor gene family in HLA-identical sibling] 20th December, 2007
Blood Center of Zhejiang Province, Key Laboratory of Blood Safety
Features and distribution of CD8 T cells with human leukocyte antigen class I-specific receptor expression in chronic hepatitis C.
CD8(+) T cells represent a sizable component of the liver inflammatory...
Direct Link
19th December, 2007
Institut National de la Sante et de la Recherche Medicale Unite 548,
Natural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severity. 6th December, 2007
Division of Experimental Medicine, Department of Medicine, University of
Impact of incompatible killer cell immunoglobulin-like receptor and its ligand on the outcome of haploidentical bone marrow transplantation. 22nd August, 2007
Department of Hematology, General Hospital of Air Force, Beijing 100036,
[Expression of NKG2D ligands in multidrug-resistant nasopharyngeal carcinoma cell line CNE2/DDP and their effects on cytotoxicity of natural killer cells] 23rd June, 2007
Department of Hematology, Zhujiang Hospital, Southern Medical University,
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional